Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 43

1.

Digenic junctional epidermolysis bullosa: mutations in COL17A1 and LAMB3 genes.

Floeth M, Bruckner-Tuderman L.

Am J Hum Genet. 1999 Dec;65(6):1530-7.

2.

A child with localized vulval pemphigoid and IgG autoantibodies targeting the C-terminus of collagen XVII/BP180.

Schumann H, Amann U, Tasanen K, Müller S, Zillikens D, Metze D, Luger T, Bruckner-Tuderman L, Bonsmann G.

Br J Dermatol. 1999 Jun;140(6):1133-8.

PMID:
10354084
3.

IgA antibodies of cicatricial pemphigoid sera specifically react with C-terminus of BP180.

Nie Z, Hashimoto T.

J Invest Dermatol. 1999 Feb;112(2):254-5. No abstract available.

4.
5.

IgG autoantibodies from bullous pemphigoid (BP) patients bind antigenic sites on both the extracellular and the intracellular domains of the BP antigen 180.

Perriard J, Jaunin F, Favre B, Büdinger L, Hertl M, Saurat JH, Borradori L.

J Invest Dermatol. 1999 Feb;112(2):141-7.

6.
7.

Type XVII collagen (BP180) and LAD-1 are present as separate trimeric complexes.

Pas HH, Kloosterhuis GJ, Nijenhuis M, de Jong MC, van der Meer JB, Jonkman MF.

J Invest Dermatol. 1999 Jan;112(1):58-61.

9.

Two forms of collagen XVII in keratinocytes. A full-length transmembrane protein and a soluble ectodomain.

Schäcke H, Schumann H, Hammami-Hauasli N, Raghunath M, Bruckner-Tuderman L.

J Biol Chem. 1998 Oct 2;273(40):25937-43.

10.

Immunological detection of conformational neoepitopes associated with the serpin activity of plasminogen activator inhibitor type-2.

Saunders DN, Buttigieg KM, Gould A, McPhun V, Baker MS.

J Biol Chem. 1998 May 1;273(18):10965-71.

11.

Interleukin-1 receptor antagonist prevents expression of the metalloproteinase-generated neoepitope VDIPEN in antigen-induced arthritis.

van Meurs JB, van Lent PL, Singer II, Bayne EK, van de Loo FA, van den Berg WB.

Arthritis Rheum. 1998 Apr;41(4):647-56.

PMID:
9550473
12.

Cleavage of BP180, a 180-kDa bullous pemphigoid antigen, yields a 120-kDa collagenous extracellular polypeptide.

Hirako Y, Usukura J, Uematsu J, Hashimoto T, Kitajima Y, Owaribe K.

J Biol Chem. 1998 Apr 17;273(16):9711-7.

13.
14.
15.

A highly sensitive enzyme-linked immunosorbent assay for the detection of circulating anti-BP180 autoantibodies in patients with bullous pemphigoid.

Zillikens D, Mascaro JM, Rose PA, Liu Z, Ewing SM, Caux F, Hoffmann RG, Diaz LA, Giudice GJ.

J Invest Dermatol. 1997 Nov;109(5):679-83.

16.

Tight clustering of extracellular BP180 epitopes recognized by bullous pemphigoid autoantibodies.

Zillikens D, Rose PA, Balding SD, Liu Z, Olague-Marchan M, Diaz LA, Giudice GJ.

J Invest Dermatol. 1997 Oct;109(4):573-9.

17.

A recombinant form of the human BP180 ectodomain forms a collagen-like homotrimeric complex.

Balding SD, Diaz LA, Giudice GJ.

Biochemistry. 1997 Jul 22;36(29):8821-30.

PMID:
9220968
18.

Three novel homozygous point mutations and a new polymorphism in the COL17A1 gene: relation to biological and clinical phenotypes of junctional epidermolysis bullosa.

Schumann H, Hammami-Hauasli N, Pulkkinen L, Mauviel A, Küster W, Lüthi U, Owaribe K, Uitto J, Bruckner-Tuderman L.

Am J Hum Genet. 1997 Jun;60(6):1344-53.

19.

Linear IgA bullous dermatosis with IgA antibodies exclusively directed against the 180- or 230-kDa epidermal antigens.

Ghohestani RF, Nicolas JF, Kanitakis J, Claudy A.

J Invest Dermatol. 1997 Jun;108(6):854-8.

20.

Enhanced cleavage of type II collagen by collagenases in osteoarthritic articular cartilage.

Billinghurst RC, Dahlberg L, Ionescu M, Reiner A, Bourne R, Rorabeck C, Mitchell P, Hambor J, Diekmann O, Tschesche H, Chen J, Van Wart H, Poole AR.

J Clin Invest. 1997 Apr 1;99(7):1534-45.

Supplemental Content

Support Center